$BLPH 3 Wall Street analysts have issued ratings and price targets for Bellerophon Therapeutics in the last 12 months. Their average twelve-month price target is $31.67, suggesting that the stock has a possible upside of 139.90%. The high price target for BLPH is $35.00 and the low price target for BLPH is $30.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy." marketbeat.com/stocks/NASDA...
  • 5
5 Likes